Clinical Trial Update: Efficacy and Safety of Specific Immunotherapy With CLUSTOID Grass Pollen [Phase 3]

View source ↗

Summary

Phase 3 trial evaluates the efficacy and safety of CLUSTOID Grass Pollen specific immunotherapy for allergic rhinitis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• CLUSTOID Grass Pollen

Snippet

Sponsor: Roxall Medizin | Conditions: Allergic Rhinitis | Phase 3 | Status: COMPLETED